Mobile Button Search>

CSR

Highlights of 2019

The vision of PharmaEssentia is to become a world-class innovative biopharmaceutical company. We aim to build a fully integrated company with our base of operations in Taiwan and with leading capabilities from R&D, pre-clinical tests and clinical trials, manufacturing, to the marketing in global markets after the drug permit licenses are obtained. This truly shows that our R&D and manufacturing are not only in line with Taiwan’s requirements, but that we are also able to extend our clinical trials and sales to European and American markets and be in line with their requirements. Through the cross-border R&D clinical cooperation model, we can not only learn from successful experiences, but we also can cultivate local talents in the field of biotechnology and biopharmaceutical industry.

A fully integrated innovative biopharmaceutical company
Two major globalization policies
R&D of innovative biopharmaceuticals
Comprehensive intellectual property rights management
Rigorous clinical trials
PIC/S GMP certified manufacturing and production
Global commercialization blueprint
Name Download
2019 CSR Report